TP53 and cancer: Furthermore, since cancer-associated TP53 mutations comprise a heterogeneous spectrum of functional defects [23–25], individual mutations might differ from each other with regard to their prognostic impact, and patient populations with different spectra of TP53 mutations might differ with regard to the role of these mutations as prognostic markers.